New insights into the pathophysiology of cobalamin deficiency

Trends in Molecular Medicine

Volumn 12, Issue 6, 2006, Pages 247-254

  Scalabrino, Giuseppe ^a   Peracchi, Maddalena ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; EPIDERMAL GROWTH FACTOR; METHYLMALONYL COENZYME A MUTASE; NEUROTOXIN; NEUROTROPHIC FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APLASTIC ANEMIA; ARTICLE; BODY FLUID; COENZYME; DISEASE ASSOCIATION; FANCONI ANEMIA; GENE EXPRESSION REGULATION; HUMAN; METHYLMALONIC ACIDEMIA; NEUROPATHY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERNICIOUS ANEMIA; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REFRACTORY ANEMIA; REMISSION; VITAMIN DEFICIENCY;

ANEMIA, PERNICIOUS; ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; EPIDERMAL GROWTH FACTOR; GASTRECTOMY; HUMANS; NERVE DEGENERATION; NERVE GROWTH FACTOR; RATS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 33744990808     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.04.008     Document Type: Article

References (74)

1. Biermer A. Über eine Form von progressiver perniciöser Anämie. Correspondenz-Blatt schw. Ärzte 2 (1872) 15-17
2. Russell J.S.R., et al. Subacute combined degeneration of the spinal cord. Brain 23 (1900) 39-110
3. Lindenbaum J., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318 (1988) 1720-1728
4. 12 (1999), John Wiley and Sons Inc. 681-706
5. 12?. Trends Biochem. Sci. 30 (2005) 304-308
6. 12) revisited. J. Neuropathol. Exp. Neurol. 60 (2001) 109-120
7. 12) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp. Neurol. 192 (2005) 463-479
8. Wickramasinghe S.N. The wide spectrum and unresolved issues of megaloblastic anemia. Semin. Hematol. 36 (1999) 3-18
9. Scalabrino G., et al. Subacute combined degeneration and induction of ornithine decarboxylase in spinal cords of totally gastrectomized rats. Lab. Invest. 62 (1990) 297-304
10. Scalabrino G., et al. Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction. Lab. Invest. 72 (1995) 114-123
11. 12-deficient rats. Br. J. Nutr. 89 (2003) 441-444
12. Scalabrino G., et al. Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. Exp. Neurol. 144 (1997) 258-265
13. Kölker S., and Okun J.G. Methylmalonic acid - an endogenous toxin?. Cell. Mol. Life Sci. 62 (2005) 621-624
14. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell. Mol. Life Sci. 61 (2004) 470-487
15. Ledley F.D., and Rosenblatt D.S. Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations. Hum. Mutat. 9 (1997) 1-6
16. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 19 (1999) 217-246
17. 12 deficiency in children and adolescents. J. Pediatr. 138 (2001) 10-17
18. 12 deficiency. N. Engl. J. Med. 348 (2003) 2208
19. Rosenblatt D.S., and Fenton W.A. Inherited disorders of folate and cobalamin transport. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic & Molecular Bases of Inherited Disease. 8th ed. (2001), Mc Graw-Hill 3897-3933
20. Perry J., et al. Methylation of DNA in megaloblastic anaemia. J. Clin. Pathol. 43 (1990) 211-212
21. Wang C.X., and Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 67 (2002) 161-172
22. Owens T., et al. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res. Brain Res. Rev. 48 (2005) 178-184
23. Kordek R., et al. Heightened expression of tumor necrosis factor α, interleukin 1α, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9754-9758
24. Connor B., and Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27 (1998) 1-39
25. Yuen E.C., and Mobley W.C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40 (1996) 346-354
26. Buccellato F., et al. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated. FASEB J. 13 (1999) 297-304
27. 12 (cobalamin) in the rat central nervous system. FASEB J. 13 (1999) 2083-2090
28. 12) positively regulates interleukin-6 levels in rat cerebrospinal fluid. J. Neuroimmunol. 127 (2002) 37-43
29. del Carmen Rodriguez M., et al. Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood 103 (2004) 3349-3354
30. Hauser S.P., et al. The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures. Stem Cells 15 (1997) 125-132
31. Otero G.C., and Merrill J.E. Cytokine receptors on glial cells. Glia 11 (1994) 117-128
32. Taga T. gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem. 67 (1996) 1-10
33. Mehler M.F., and Kessler J.A. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci. 20 (1997) 357-365
34. 12) deficiency. Neurosci. Lett. 396 (2006) 153-158
35. 12 (cobalamin) in the rat central nervous system. J. Neuropathol. Exp. Neurol. 59 (2000) 808-814
36. Chitnis T., and Khoury S.J. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol. Res. 28 (2003) 223-239
37. Peracchi M., et al. Human cobalamin deficiency: alterations in serum tumor necrosis factor-α and epidermal growth factor. Eur. J. Haematol. 67 (2001) 123-127
38. Scalabrino G., et al. High tumor necrosis factor-α levels in cerebrospinal fluid of cobalamin-deficient patients. Ann. Neurol. 56 (2004) 886-890
39. 12) and folate deficiency. FASEB J. 7 (1993) 1344-1353
40. Antony A.C. Megaloblastic anemias. In: Hoffman R., Benz Jr. E.J., Shattil S.J., Furie B., Cohen H.J., Silberstein L.E., and McGlave P. (Eds). Hematology. 4th ed. (2005), Elsevier 519-556
41. Davidsson P., et al. Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 1 (2001) 444-452
42. 12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid. Biochem. J. 374 (2003) 239-246
43. 12 in genomic stability of human cells. Mutat. Res. 475 (2001) 57-67
44. 12. J. Biol. Chem. 278 (2003) 20778-20784
45. Kaput J., and Rodriguez R.L. Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 16 (2004) 166-177
46. Jeffery C.J. Moonlighting proteins: old proteins learning new tricks. Trends Genet. 19 (2003) 415-417
47. Jeffery C.J. Moonlighting proteins. Trends Biochem. Sci. 24 (1999) 8-11
48. Sutter M.C. Assigning causation in disease: beyond Koch's postulates. Perspect. Biol. Med. 39 (1996) 581-592
49. Popper K.R. A survey of some fundamental problems. The Logic of Scientific Discovery (1959), Hutchinson pp. 27-48
50. Hara T., et al. Excessive production of tumor necrosis factor-α by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur. J. Haematol. 73 (2004) 10-16
51. Dubey S., et al. Expression of interferon-γ and tumor necrosis factor-α in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann. Hematol. 84 (2005) 572-577
52. Dufour C., et al. TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro. Blood 102 (2003) 2053-2059
53. Koury M.J., et al. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent nucleoside-reversible mechanism. Blood 96 (2000) 3249-3255
54. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 18 (2004) 1176-1199
55. Wickramasinghe S.N. Morphology, biology and biochemistry of cobalamin- and folate-deficient bone marrow cells. Baillière's Clin. Haematol. 8 (1995) 441-459
56. Helmrath M.A., et al. Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. Lancet 351 (1998) 266-267
57. Shin C.E., et al. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J. Pediatr. Surg. 35 (2000) 173-176
58. Shelton J.G., et al. Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line. Cell Cycle 4 (2005) 818-821
59. Watson W.H., et al. S-Adenosylmethionine attenuates the lipopolysaccharide-induced expression of gene of tumor necrosis factor α. Biochem. J. 342 (1999) 21-25
60. Veal N., et al. Inhibition of lipopolysaccharide-stimulated TNF-α promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. Am. J. Physiol Gastrointest Liver Physiol. 287 (2004) G352-G362
61. 12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized rats. Digestion 68 (2003) 133-140
62. Su S.-J., et al. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor espression. Nutrition 21 (2005) 994-1002
63. Wickramasinghe, S.N. (1975) Some aspects of abnormal erythropoiesis and granolucytopoiesis. In Human Bone Marrow. pp. 293-367, Blackwell Scientific Publications
64. Tsaioun K.I. Vitamin K-dependent proteins in the developing and aging nervous system. Nutr. Rev. 57 (1999) 231-240
65. Garcion E., et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13 (2002) 100-105
66. Dusso, A.S. et al. (2005) Vitamin D. Am. J. Physiol. 289, F8-28
67. Costello J.F., and Plass C. Methylation matters. J. Med. Genet. 38 (2001) 285-303
68. Liu L., et al. Aging, cancer and nutrition: the DNA methylation connection. Mech. Ageing Dev. 124 (2003) 989-998
69. Armstong R.J., and Barker R.A. Neurodegeneration: a failure of neuroregeneration?. Lancet 358 (2001) 1174-1176
70. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 6 (2005) 597-610
71. Stabler S.P., et al. Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency. Neurology 41 (1991) 1627-1632
72. 12 absorption following partial gastrectomy. Acta Neurol. Scand. 59 Suppl. 69 (1978) 1-77
73. Pant S.S., et al. The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol. Scand. 44 Suppl. 35 (1968) 1-36
74. Savage D.G., and Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillière's Clin. Haematol. 8 (1995) 657-678